Bruker reports Q3 2026 revenue up 1.6% and non‑GAAP EPS of $0.56, reaffirming FY 2026 guidance
Bruker Corporation posted third‑quarter 2026 revenue of $874.0 million, a 1.6% increase year‑over‑year on a reported basis and 0.7% organic growth. Non‑GAAP diluted earnings per share were $0.56, up 24.4% from the prior year, while GAAP results showed a loss per share of $(0.81) after a $174.5 million goodwill impairment. The company reaffirmed its FY 2026 outlook of 1%‑2% organic revenue growth and non‑GAAP EPS of $2.10‑$2.15, and highlighted continued margin expansion and strong bookings in its Bruker Scientific Instruments segment.
Why it matters
The reaffirmed FY 2026 guidance signals that investors can expect modest top‑line growth and 15%‑17% non‑GAAP EPS growth year‑over‑year, according to the company’s filing. The 400‑basis‑point rise in non‑GAAP operating margin to 16.3% improves profitability outlook.
Key facts
- 1Q3 2026 reported revenue was $874.0 million, up 1.6% year‑over‑year (reported basis). sec.gov
- 2Q3 2026 organic revenue growth was 0.7% year‑over‑year. sec.gov
- 3Non‑GAAP diluted EPS for Q3 2026 was $0.56, up 24.4% from Q3 2025 (non‑GAAP basis). sec.gov
- 4GAAP diluted loss per share for Q3 2026 was $(0.81). sec.gov
- 5Non‑GAAP operating margin for Q3 2026 was 16.3%, an increase of 400 basis points year‑over‑year (non‑GAAP basis). sec.gov
- 6FY 2026 guidance: organic revenue growth of 1%‑2% and non‑GAAP EPS of $2.10‑$2.15. sec.gov
Summary written by AlphAI AI Desk from 17 of 17 sources. Not investment advice. Figures are as stated by the linked sources.